Computed tomography-based radiomics quantification predicts epidermal growth factor receptor mutation status and efficacy of first-line targeted therapy in lung adenocarcinoma

BACKGROUND: Biomarkers that predict the efficacy of first-line tyrosine kinase inhibitors (TKIs) are pivotal in epidermal growth factor receptor (EGFR) mutant advanced lung adenocarcinoma. Imaging-based biomarkers have attracted much attention in anticancer therapy. This study aims to use the machin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Meilin, Yang, Pei, Li, Jing, Peng, Wenying, Pu, Xingxiang, Chen, Bolin, Li, Jia, Wang, Jingyi, Wu, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424619/
https://www.ncbi.nlm.nih.gov/pubmed/36052262
http://dx.doi.org/10.3389/fonc.2022.985284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424619/
https://www.ncbi.nlm.nih.gov/pubmed/36052262
http://dx.doi.org/10.3389/fonc.2022.985284

Ejemplares similares